Identity
Janssen Cilag, S.A.
| Year | Amount | Distribution |
|---|---|---|
| 2026* | €308.3M | |
| 2025 | €333.3M | |
| 2024 | €197.2M | |
| + regional platforms | ||
| 2023 | €97.2M | |
| 2022 | €111.7M | |
| 2021 | €140.3M | |
| 2020 | €20.4M | |
| 2019 | €51.3M | |
| 2018 | €14.6M | |
| 2017 | €13.9M | |
| 2016 | €4.2M | |
In figures
Volume
Between 2016 and 2026 it won 1,272 contracts worth €1,292M on its own, with 49 buyers. Its 10 joint-venture (UTE) contracts are shown separately.
Price
In 2024–2025 its median discount was 19.6%; the middle half of its discounts between 14.4% and 26.8% (3 comparable awards).
Competition
Since 2024, 17% of its comparable value was won with a discount and against other bidders. It was the only bidder in 95% of its contracts (2016–2026).
Renewals
70 contracts (€106M) come up for tender again in the next 24 months.
A UTE is a temporary joint venture: the contract is awarded to the UTE and each partner's share is not published. That is why these contracts are not added to Janssen Cilag, S.A.'s total, and under «Show UTEs» the amounts are the full value of each contract (100%), not Janssen Cilag, S.A.'s share.
Data up to 31 October 2026 · updated on 12 November 2026 · Source: official data, national and regional coverage
| UTE partners | Contracts | Total value (100 %) |
|---|
Its discounts
The discount at which it wins contested contracts, year by year.
2024–2025: median 19.6% · middle half between 14.4% and 26.8% · 3 awards
2019–2025: median 14.4% · middle half between 8.3% and 23.2% · 4 awards
Discount on the tender budget, excluding VAT, on awards above the minor-contract threshold · Source: official data, national and regional coverage. Methodology →
Where it wins, and at what discount
In the report · these discounts, one by one
Each dot on the chart is an award. The report lists them all and groups them by buyer and by sector, next to the discounts of other companies with the same buyers.
Full list: date, buyer, amount, budget, discount, bidders and a link to the official publication.
3 awards at the tender price, left out of the discounts.
How it wins
Whether it wins with or without competition.
58% of the comparable value since 2024 (€3.16M of €5.45M) was won with a discount and without other bidders. €1.39M (25%) was awarded at the tender price and without other bidders.
Comparable: 20 awards with a published budget and bidder count (€5.45M of €839M awarded since 2024). Percentages of value; the figure next to «bidders» is the number of awards. Source: official data, national and regional coverage.
Between 2016 and 2026, 74.7% of the value was awarded through negotiated without publicity procedure (49.9% of contracts); followed by Based on a framework agreement (10.1%) and Open (8.1%).
Upcoming tenders and main buyers
When its contracts come back and who it sells to.
In the next 24 months 70 of its contracts come up for tender again, worth €106M.
| Expected end | Buyer | Value |
|---|---|---|
| 2026 | Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad | €26.7M |
| 2026 | Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad | €4.73M |
| 2026 | Gerencia del Área de Salud de Plasencia | €353k |
| 2026 | Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad | — |
| 2026 | Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad | — |
and 65 more in the next 24 months · the report includes them all
Expected end year from the published duration (no extensions). The report includes the month and the discount it won each one at.
| Buyer | Contracts | Value, € | Period |
|---|---|---|---|
| OSAKIDETZA - Servicio Vasco de Salud -Director General | 28 | 258 M | 2024–2026 |
| Subsecretaría de la Consellería de Sanidad y Salud Pública | 44 | 222 M | 2020–2026 |
| Gerencia de Servicio Sanitarios de Fuerteventura | 631 | 185 M | 2018–2026 |
| Servicio Andaluz de Salud | 84 | 148 M | 2024–2026 |
| Servicio Murciano de Salud - Junta de Compras | 49 | 91 M | 2021–2026 |
and 44 more buyers
Between 2016 and 2026, 100.0% of the value it won on its own is in Medical & pharmaceuticals (CPV 33, 1,251 contracts).
Recent awards
The evidence behind every insight in the report.
| Date | Contract | Buyer | Bidders | Value |
|---|---|---|---|---|
| 10/09/2026 | Acuerdo Marco para el suministro de medicamentos sin competencia para los hospitales del Servicio C… | Servicio Cántabro de Salud | 1 | €3.05k |
| 11/08/2026 | Suministro de Ciltacabtagen Autoleucel. "Emergencia": | Servicio Cántabro de Salud | 1 | — |
| 26/06/2026 | 1º Contrato derivado de Acuerdo Marco, Suministro de TREVICTA_BYANNLI® para los Centros Penitenciar… | Subdirección General de Planificación y Gestión Económica | 1 | €348k |
| 18/06/2026 | Suministro de medicamentos de uso humano tipo ii (exclusivos), lotes 116 y 128, con destino al serv… | Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 1 | €50.9k |
| 08/06/2026 | cpca 1º cbam janssen cilag, s.a. exp. 578/2025 suministro medicamentos exclusivos, cca: +6.i+e9q8j | Servicio Andaluz de Salud | 1 | €1.90M |